AU7050196A - Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans - Google Patents

Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans

Info

Publication number
AU7050196A
AU7050196A AU70501/96A AU7050196A AU7050196A AU 7050196 A AU7050196 A AU 7050196A AU 70501/96 A AU70501/96 A AU 70501/96A AU 7050196 A AU7050196 A AU 7050196A AU 7050196 A AU7050196 A AU 7050196A
Authority
AU
Australia
Prior art keywords
zeaxanthin
stereoisomer
humans
pure
macular degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU70501/96A
Other versions
AU710634B2 (en
Inventor
Kevin M. Garnett
Dennis L. Gierhart
Luis H. Guerra-Santos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZeaVision LLC
Original Assignee
ZeaVision LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Application filed by ZeaVision LLC filed Critical ZeaVision LLC
Publication of AU7050196A publication Critical patent/AU7050196A/en
Application granted granted Critical
Publication of AU710634B2 publication Critical patent/AU710634B2/en
Assigned to ZEAVISION, L.L.C. reassignment ZEAVISION, L.L.C. Alteration of Name(s) in Register under S187 Assignors: APPLIED FOOD BIOTECHNOLOGY, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU70501/96A 1995-10-31 1996-10-30 Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans Ceased AU710634B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/551153 1995-10-31
US08/551166 1995-10-31
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion

Publications (2)

Publication Number Publication Date
AU7050196A true AU7050196A (en) 1997-05-08
AU710634B2 AU710634B2 (en) 1999-09-23

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70501/96A Ceased AU710634B2 (en) 1995-10-31 1996-10-30 Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans

Country Status (14)

Country Link
JP (1) JPH10512594A (en)
KR (1) KR100570251B1 (en)
CN (1) CN1104235C (en)
AR (1) AR004245A1 (en)
AU (1) AU710634B2 (en)
BR (1) BR9611488A (en)
CZ (1) CZ297575B6 (en)
FI (1) FI980947A (en)
HU (1) HU223208B1 (en)
NO (1) NO981698L (en)
PL (1) PL185465B1 (en)
RU (1) RU2197958C2 (en)
WO (1) WO1997016175A1 (en)
ZA (1) ZA969139B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) * 2005-01-21 2005-03-02 Promar As Compositions
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
AU2006213635B2 (en) * 2005-02-11 2010-06-17 Kalamazoo Holdings, Inc. A Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
WO1991003571A1 (en) * 1989-08-30 1991-03-21 Applied Food Biotechnology, Inc. Production of zeaxanthin and zeaxanthin-containing compositions
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene

Also Published As

Publication number Publication date
NO981698D0 (en) 1998-04-16
AR004245A1 (en) 1998-11-04
HUP9802314A3 (en) 1999-05-28
CN1104235C (en) 2003-04-02
PL185465B1 (en) 2003-05-30
CZ297575B6 (en) 2007-02-07
MX9605248A (en) 1998-06-30
HUP9802314A2 (en) 1999-04-28
ZA969139B (en) 1997-09-25
RU2197958C2 (en) 2003-02-10
KR19990067180A (en) 1999-08-16
NO981698L (en) 1998-06-08
CZ130998A3 (en) 1998-07-15
BR9611488A (en) 1999-01-19
JPH10512594A (en) 1998-12-02
WO1997016175A1 (en) 1997-05-09
FI980947A0 (en) 1996-10-30
KR100570251B1 (en) 2006-06-21
HU223208B1 (en) 2004-03-29
PL326558A1 (en) 1998-09-28
FI980947A (en) 1998-04-29
AU710634B2 (en) 1999-09-23
CN1201388A (en) 1998-12-09

Similar Documents

Publication Publication Date Title
IL117793A0 (en) Method for the treatment of macular degeneration
AU5499896A (en) Hair treatment compositions
AU4104896A (en) Stable lycopene concentrates and process for their preparation
AU7419096A (en) Treatment of vegetables
AU6275796A (en) Skin treatment process using laser
AU2041195A (en) Process of sterilization
AUPN271295A0 (en) Method of treatment
AU6525296A (en) Wound treatment composition
AU6252196A (en) Methods for controlling highly unsaturated fatty acid content in various tissues
AU3584895A (en) Method of treating macular degeneration using tgf-beta
AU3768795A (en) Method and compositions for hair treatment
AU1660297A (en) Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido (1,2a) indol -carbocylic acids and their activated derivatives
AU5315096A (en) 19-oxygenated steroids as therapeutic agents
AU7050196A (en) Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans
AU7498296A (en) Use of protein gax for treating cancer
AU1249395A (en) Topical treatment of ocular photophobia
AU7174294A (en) Compositions for treating hypoxia-associated ocular complications
AU3137095A (en) Ophthalmic compositions for treating glaucoma
AU697193B2 (en) Antiseptic dermatological composition and process for its manufacture
AUPN104895A0 (en) Methods of and preparations for the treatment of ailments and disorders
AU7096496A (en) Process for the preparation of 4-methylenepiperidines
AU5486396A (en) Process for the preparation of spiroindolines
AUPN499895A0 (en) Hair treatment composition
AU5699396A (en) Compositions for the treatment of skin conditions
AU2838697A (en) Process for the preparation of pesticides